Replies to post #240519 on Biotech Values

[DewDiligence]

Botulinum-toxin therapy for dry/wet AMD is intriguing! Although the addressable worldwide market is colossal, dry AMD has no approved therapy, and wet AMD hasn’t had a genuinely new MoA in 15 years.

The item in the post above may be a ping where in a couple of years people say, “How did I miss that?”